Business · NEWS EXPLAINER
AkzoNobel lifts Q3 organic sales and margin while portfolio sale marks $1.35bn milestone
Pricing lifted organic sales 2% and adjusted EBITDA margin to 15.3%, while adjusted EBITDA of €388 million narrowly topped consensus. A South-East Asia paint-business sale agreement adds a separate portfolio-value milestone.
AkzoNobel reported a modest third-quarter earnings beat as pricing and cost actions offset difficult markets. The result matters less for a one-million-euro consensus difference than for the mix behind it: organic sales rose, margin expanded for a sixth quarter, cash generation slowed, and a large portfolio sale agreement moved the group toward a reshaped asset base.
Pricing, not reported revenue, drove the top line
Organic sales increased 2% from a year earlier, led by pricing, while reported revenue was broadly flat at €2.538 billion versus €2.547 billion. That distinction matters because AkzoNobel’s organic measure excludes changes in consolidation, foreign exchange and hyperinflation accounting. The company specifically notes portfolio changes including earlier Asian liquid-coatings divestments and the 2026 deconsolidation of Russian entities.
The margin improved, but the beat was narrow
Adjusted EBITDA was €388 million, up from €385 million. Reuters said that was one million euros above the company-provided analyst consensus of €387 million. On a comparable basis, AkzoNobel described organic adjusted EBITDA growth of €15 million, or 4%, and the adjusted EBITDA margin increased to 15.3% from 15.1%. The company attributes the improvement to pricing and its cost-savings plan; the reported figures do not support treating the small consensus beat as a broad demand surge.
Cash flow weakened and operating income tells a different story
Net cash from operating activities was €187 million, down from €331 million a year earlier. Reported operating income was negative €73 million, compared with negative €29 million in Q3 2025, with the company saying it was affected by the Russia deconsolidation and Pakistan divestment. Those reported items sit outside the adjusted EBITDA narrative, so readers should not use one measure as a substitute for the other.
The $1.35 billion sale agreement is separate from quarterly trading
AkzoNobel signed binding agreements to sell its Decorative Paints business in South-East Asia for $1.35 billion, which it described as 21 times the business’s FY2025 EBITDA. The announcement is a portfolio transaction, not Q3 operating revenue, and the release presents it as the conclusion of a strategic review of the Asian paints portfolio. Until completion conditions are met, the agreement should be described as signed rather than as closed cash proceeds.
Guidance holds, with currency and divestment caveats
AkzoNobel expects around €100 million of adjusted EBITDA improvement in constant currencies and full-year 2026 adjusted EBITDA of around €1.47 billion, using end-2025 exchange rates and adjusting for divestments of Asian liquid-coatings businesses. It targets leverage around two times net debt to adjusted EBITDA by year-end. The proposed Axalta merger remains subject to regulatory approvals and is expected to close in early 2027; those conditions make both the outlook and transaction timetable forward-looking rather than guaranteed.
